Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
|Articles|May 8, 2006
Pharmacy executive group changes name
The National Council of State Pharmacy Association Executives hasvoted to change its name to the National Alliance of State PharmacyAssociations (NASPA)
Advertisement
The National Council of State Pharmacy Association Executives has voted to change its name to the National Alliance of State Pharmacy Associations (NASPA). The mission of NASPA is to enable association executives to improve their work and service by sharing ideas and pursuing activities that benefit the state pharmacy associations and their members.
To see more Hot off the Press news articles, click here
To go to the Drug Topics homepage,
Advertisement
Related to this article
To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
Advertisement
Advertisement
Trending on Drug Topics
1
EloraTZP Shows Greater Weight Loss, A1C Reduction Than Tirzepatide
2
FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B
3
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
4
Tailored Prevention, Care Necessary in Addressing Viral CAP
5